Inventor · disambiguated record
Fred J. Fleitz
Also filed as: FLEITZ FRED · FLEITZ FRED J
17 granted patents·4 pending applications·62 citations·filing 2002–2024
93Inventor score
Files withARROWHEAD PHARMACEUTICALS INC7CODEXIS INC5OTSUKA AMERICA PHARMACEUTICAL INC3NEUROVANCE INC2HUGHES GREGORY1
Top patents by PatentIndex Score
21 records- 0193US11371067B2Transaminase reactionsCODEXIS INC·Filed 2020·Granted Jun 28, 2022·2 cites·21 claims
- 0292US10294474B2Targeting ligandsARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted May 21, 2019·15 cites·50 claims
- 0392US10246709B2Targeting ligands for therapeutic compoundsARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted Apr 2, 2019·10 cites·27 claims
- 0491US9434968B2Transaminase reactionsCODEXIS INC·Filed 2014·Granted Sep 6, 2016·6 cites·10 claims
- 0589US11174481B2Targeting ligandsARROWHEAD PHARMACEUTICALS INC·Filed 2019·Granted Nov 16, 2021·3 cites·4 claims
- 0688US10138503B2Transaminase reactionsCODEXIS INC·Filed 2016·Granted Nov 27, 2018·2 cites·22 claims
- 0788US9708261B2Crystalline compoundsNEUROVANCE INC·Filed 2016·Granted Jul 18, 2017·6 cites·32 claims
- 0887US10800740B2Crystalline compoundsOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2019·Granted Oct 13, 2020·2 cites·26 claims
- 0987US2025243485A1Targeting Ligands For Therapeutic CompoundsARROWHEAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1086US9856217B2Crystalline compoundsNEUROVANCE INC·Filed 2017·Granted Jan 2, 2018·4 cites·14 claims
- 1185US11299458B2Crystalline compoundsOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2020·Granted Apr 12, 2022·1 cites·10 claims
- 1285US8921079B2Transaminase reactionsHUGHES GREGORY·Filed 2010·Granted Dec 30, 2014·6 cites·10 claims
- 1384US10767202B2Transaminase reactionsCODEXIS INC·Filed 2018·Granted Sep 8, 2020·1 cites·22 claims
- 1484US10280141B2Crystalline compoundsOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2017·Granted May 7, 2019·3 cites·40 claims
- 1581US12247233B2Transaminase reactionsCODEXIS INC·Filed 2022·Granted Mar 11, 2025·0 cites·8 claims
- 1676US12116573B2Targeting ligands for therapeutic compoundsARROWHEAD PHARMACEUTICALS INC·Filed 2021·Granted Oct 15, 2024·0 cites·3 claims
- 1767US2022033817A1Targeting LigandsARROWHEAD PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1862US2019211333A1Targeting Ligands For Therapeutic CompoundsARROWHEAD PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1957US7361765B2Process for the preparation of CCR-2 antagonistsMERCK & CO INC·Filed 2004·Granted Apr 22, 2008·1 cites·7 claims
- 2041US9441254B2Process for the preparation of an intermediate for an orexin receptor antagonistMERCK SHARP & DOHME·Filed 2013·Granted Sep 13, 2016·0 cites·11 claims
- 2136US2003125336A1Hydrohalide salts of an HIV protease inhibitorFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fred J. Fleitz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →